PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG-TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS

• Ares Guardia-Torrelles,
• Carlos Jimenez-Vicente,
• Alexandra Martínez Roca,
• Sandra Castaño-Díez,
• Helena Brillembourg,
• Francesca Guijarro,
• Àlex Bataller,
• Daniel Esteban,
• Albert Cortés,
• Inés Zugasti,
• Daniel Munarriz,
• Marina Diaz-Beya,
• Jordi Esteve,
• Beatriz Merchan

Affiliations

Ares Guardia-Torrelles

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Carlos Jimenez-Vicente

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Alexandra Martínez Roca

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Sandra Castaño-Díez

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Helena Brillembourg

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Francesca Guijarro

2 University of Barcelona, Barcelona, Spain

Àlex Bataller

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Daniel Esteban

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Albert Cortés

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Inés Zugasti

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Daniel Munarriz

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Marina Diaz-Beya

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Jordi Esteve

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain

Beatriz Merchan

1 Hospital Clínic Barcelona, Hematology Department, Barcelona, Spain